 |
||||||
|
 |
 |
 |
 |
 |
|
|
|
|
HITS Updates |
||
|
Updated 14-Jan-05
The next phase of the HITS research program is underway. With the help of funding from the National Institutes of Health, and with islet isolation procedures refined by the Puget Sound Blood Center, islet after kidney transplants are being undertaken at Swedish Medical Center. One of the proposed benefits for patients of the islet-after-kidney protocol is that a successful immunosuppressive regimen has already been introduced. As a result, it is expected that patients with this kind of islet transplantation will not need additional immunosuppression to protect their new islets from rejection. The protocol for the current islet-after-kidney procedures calls for infusion of the islets into the portal vein of the liver, the location currently used by most researchers for transplanted islets. A subsequent protocol being developed by HITS will involve placing the islets in other sites.
Patients who wish to participate in the HITS transplant research program should consult the eligibility criteria with their physician to consider whether they meet the criteria for participation. If they appear to be eligible, their doctor should contact Dr. Paul Robertson at PNRI (206-726-1200) to discuss their possible participation in the research. News ReleasesSeattle Times Article About Islet TransplantationPosted 14-Jan-05
Read a Seattle Times article about islet transplantation, featuring Dr. Paul Robertson, CEO and Scientific Director of the Pacific Northwest Research Institute (PNRI), and a major review article he published in the New England Journal of Medicine.
Read the full story (free registration required)
Dr. Paul Robertson Opens 3rd Annual Annenberg SymposiumPosted 10-Dec-03
Dr. Paul Robertson, CEO and Scientific Director of the Pacific Northwest Research Institute (PNRI), opened the 3rd Annual Annenberg Symposium on Islet Transplantation December 4, 2003. This year's program included an international roster of scientists and surgeons reporting on the clinical and basic science of islet transplantation, today's most promising therapy for type 1 diabetes.
Looking to the Future of Human Islet TransplantationPosted 12-May-03
HITS project director, Dr. Paul Robertson, looked to the future at this spring's ADA-sponsored Diabetes Expo. Drawing on the results of phase one of the islet program in Seattle, Robertson summarized for the audience four important questions involved in improving human islet transplantation for type 1 diabetes.
JDRF Islet Transplantation Center Highlighted at Seattle SymposiumPosted 12-Nov-02
The JDRF Center for Human Islet Transplantation in Seattle presented highlights of its research at a diabetes symposium held October 19 in Seattle.
First Seattle Patients Receive Islet TransplantsPosted 30-Jul-02
A clinical research team in Seattle, under the program leadership of PNRI, has performed the first three human islet transplants in the Northwest. Read the press release describing their results.
|
||
|
|
|
top of page |
Home | Participation in HITS | HITS Members | HITS Updates | FAQs PNRI Home Last modified: 14-Jan-05 All content copyright © HITS, 2002-5. Please read our disclaimer. |